Home / Stocks / ANIP

ANIP insider trading

ANI PHARMACEUTICALS INC — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-13Lalwani Nikhil
PRESIDENT & CEO
Sold55,000$77.57$4.3M
2025-11-14Gassert Chad
SVP - CORP. DEV. & STRATEGY
Sold14,642$89.07$1.3M
2025-08-22Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Sold100,000$90.36$9.0M
2025-08-20Thoma Jeanne
Director
Sold14,675$88.87$1.3M
2025-08-18Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Sold100,000$88.25$8.8M
2025-08-18Gassert Chad
SVP - CORP. DEV. & STRATEGY
Sold20,000$86.97$1.7M
2025-08-14Lalwani Nikhil
PRESIDENT & CEO
Sold56,960$85.93$4.9M
2025-08-14CAREY STEPHEN P.
SVP & CFO
Sold50,000$86.07$4.3M
2025-08-14HAUGHEY THOMAS
Director
Sold19,341$85.93$1.7M
2024-11-27Lalwani Nikhil
PRESIDENT & CEO
Sold30,000$57.95$1.7M

See ANIP on the chart

Every insider buy and sell for ANIP plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.